Momenta Pharmaceuticals
Industry / private company
Location:
Cambridge, MA,
United States (USA) (US)
ISNI: 0000000404102872
ROR: https://ror.org/01xdkk717
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. (2016)
Ortiz DF, Lansing JC, Rutitzky L, Kurtagic E, Prod'Homme T, Choudhury A, Washburn N, et al.
Journal article
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. (2015)
Washburn N, Schwab I, Ortiz D, Bhatnagar N, Lansing JC, Medeiros A, Tyler S, et al.
Journal article